Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Press Releases

Filter articles using the following links
  • Financial press releases
  • Events & presentations
27 September 2023

GenSight Biologics Provides Update on European Medicines Agency Scientific Advice for LUMEVOQ®

18 September 2023

GenSight Biologics Announces Successful Manufacture of LUMEVOQ® GMP Batch

15 September 2023

GenSight Biologics Reports Interim Financial Results for the First Half of 2023

03 August 2023

GenSight Biologics obtains funding of €10 million from Sofinnova Partners, Invus and UPMC Enterprises

20 July 2023

GenSight Biologics Provides Financial and Operational Update

31 May 2023

Annual General Meeting on June 21, 2023

10 May 2023

GenSight Biologics Announces the Filing of its 2022 Universal Registration Document and Reschedules its Annual General Meeting on June 21, 2023

21 April 2023

GenSight Biologics Reports Cash Position as of March 31, 2023, and Provides Business Update

20 April 2023

GenSight Biologics Withdraws its EMA Application for LUMEVOQ®

04 April 2023

GenSight Biologics to Host a Webcast on April 5, 2023, to Provide an Update on LUMEVOQ® Manufacturing Following Investigations Findings

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 37
  • View next 9 articles
© 2023 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page